Glenmark responds to DCGI letter seeking clarification on Fabiflu

📅 21 July 2020
👤 ANI
Mumbai July 21

I

n response to the DCGI letter seeking clarification on FabiFlu, Glenmark Pharmaceuticals Ltd, a research-led, integrated global pharmaceutical company, has responded back. Please click the link below, to access the response letter.

PDF https//mma.prnewswire.com/media/1217258/Glenmark_Response_DCGI.pdf

This story is provided by PRNewswire. ANI will not be responsible in any way for the content of this article. (ANI/PRNewswire)

✔️ Glenmark responds to DCGI letter seeking clarification on Fabiflu

📝 Post your comments

💕 Found this article helpful? Spread the word and support us!